Nov 21, 2023 7:00am EST Augmedix Announces Closing of Public Offering of Common Stock, Including Additional Investments from HCA Healthcare and Redmile Group
Nov 16, 2023 12:15am EST Augmedix Announces Pricing of Upsized Public Offering of 6,250,000 Shares of Common Stock
Nov 15, 2023 4:02pm EST Augmedix Announces Proposed Public Offering of 5,500,000 Shares of Common Stock
Nov 06, 2023 4:02pm EST Augmedix Delivers 50% Revenue Growth and Expanded Gross Margins for Third Quarter of 2023
Oct 30, 2023 7:00am EDT Augmedix to Announce Third Quarter 2023 Financial Results and Host Investor Conference Call on November 6, 2023
Oct 05, 2023 7:00am EDT Augmedix Forging Strategic Partnerships for an Open Network of Digital Health Solutions
Sep 27, 2023 7:00am EDT Augmedix Announces New AI Medical Documentation Product, Augmedix Go, a Clinician-Controlled Mobile App
Sep 06, 2023 7:00am EDT Augmedix Announces Expanding Coverage in Behavioral Health Field for Acute and Ambulatory Care Settings
Aug 24, 2023 7:00am EDT Augmedix Achieves HITRUST Certification to Further Mitigate Risk in Third-Party Privacy, Security and Compliance
